World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN27312734
Date of registration: 30/07/2012
Prospective Registration: No
Primary sponsor: Barts and The London Trust (UK)
Public title: Does ?Accelerated Partner Therapy" ( two new models of care which emphasise rapid treatment and which will be different from traditional clinic-based methods) reduce delays in the assessment and treatment of sexual partners of people with bacterial sexually transmitted infections
Scientific title: Can ?Accelerated Partner Therapy? (APT) improve outcomes of partner notification? A feasibility study and exploratory trial
Date of first enrolment: 01/11/2007
Target sample size: 300
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN27312734
Study type:  Interventional
Study design:  Non-randomised; Interventional; Design type: Treatment (Treatment)  
Phase:  Not Applicable
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Lorna    Sutcliffe
Address:  St Bartholomew's Hospital Centre for Infectious Disease: Sexual Health & HIV Barts & The London School of Medicine & Dentistry Barts Sexual Health Centre, Kenton & Lucas Wing, St. Bartholomews Hospital West Smithfield EC1A 7BE London United Kingdom
Telephone: -
Email: l.j.sutcliffe@qmul.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Index patients who are 16 years and older
2. Have tested positive for Chlamydia and/or Gonorrhoea (men and women)
3. Men who have been diagnosed with non-gonococcal urethritis (NGU) and have at least one contactable partner

Exclusion criteria: Will be determined by a suitabily qualified health professional are:
1. Pregnancy
2. Symptoms of complicated infection, allergy or contraindications to Azithromycin and or Cefixime
3. Inability to read English
4. An inability to understand instructions and give consent
5. Co-existent infection with syphilis and/or HIV as these cases require different investigation and management


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Topic: Infection; Subtopic: Infection (all Subtopics); Disease: Infectious diseases and microbiology
Infections and Infestations
Gonococcal infection
Intervention(s)
APT Hotline: Index diagnosed, treated & given APT PIN
1. Sex partner calls APT hotline for telephone consultation with clinic Health adviser/Nurse practitioner
2. Index takes or Sex partner collects APT Pack from clinic reception
3. Sex partner attends clinic for Human immunodeficiency virus (HIV) & test at later stage
4. Index & contact follow up call

APT Pharmacy, Index diagnosed, treated & given APT PIN
1. Sex partner attends pharmacy for consultation: trained pharmacist under Patient Group Directions (PGD) gives APT Pack
2. Sex partner attends clinic for HIV test at later stage
3. Index & contact follow up call
Primary Outcome(s)
Proportion of index patients having at least one partner treated 4-6 weeks after intial diagnosis
Secondary Outcome(s)
1. Proportion of regular partners treated
2. Number of contacts treated per index patient
Secondary ID(s)
2564
Source(s) of Monetary Support
Medical Research Council (MRC) (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history